Picton Mahoney Asset Management Akero Therapeutics, Inc. Transaction History
Picton Mahoney Asset Management
- $5.81 Billion
- Q1 2025
A detailed history of Picton Mahoney Asset Management transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Picton Mahoney Asset Management holds 33,611 shares of AKRO stock, worth $1.66 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
33,611Holding current value
$1.66 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
273Shares Held
85.7MCall Options Held
1.02MPut Options Held
823K-
Rtw Investments, LP New York, NY7.42MShares$365 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$348 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$292 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$275 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$258 Million7.15% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.29B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...